Summary

Please note: Individual results shown. Outcomes vary and cannot be guaranteed. These results are specific to this patient only.

This patient underwent UVB therapy for vitiligo, showing  improvement from October 2023 to January 2025. Noticeable changes began as early as April 2024, with steady repigmentation and a more even skin tone achieved over time. The results highlight the effectiveness of consistent UVB therapy in managing vitiligo.

UVB treatment is covered by Medicare, meaning there are no out-of-pocket expenses for the treatment itself. However, there will be a fee for the initial and follow-up consultations with our dermatologist.